Edarbyclor
Payments companies reported to CMS as associated with Edarbyclor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Edarbyclor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Edarbyclor
These are the largest totals companies reported as associated with Edarbyclor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mary Butcher | Columbus, OH | Family Medicine | $705.90 |
| James Corpus | Westlake, OH | Family Medicine | $535.09 |
| Ravi Krishnan | Mayfield Village, OH | Internal Medicine | $389.07 |
| Tamar Bejanishvili | Bedford, OH | Internal Medicine | $325.36 |
| Muhammed Zahra | Cleveland, OH | Cardiovascular Disease | $282.87 |
| Manavendra Bakhshi | Philadelphia, PA | Cardiovascular Disease | $228.79 |
| Mark Simon | Massillon, OH | Family Medicine | $192.14 |
| John Hollowell | Plano, TX | Cardiovascular Disease | $181.52 |
| Lyndsey Decesare | Mayfield Village, OH | Nurse Practitioner | $154.08 |
| Agustus Beck | Chardon, OH | Internal Medicine | $146.59 |
Prescribed Edarbyclor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.